相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Subcutaneous Golimumab Maintains Clinical Response in Patients With Moderate-to-Severe Ulcerative Colitis
William J. Sandborn et al.
GASTROENTEROLOGY (2014)
Review article: the role of anti-TNF in the management of ulcerative colitis past, present and future
S. Danese et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
IL-22 is related to development of human colon cancer by activation of STAT3
Runqiu Jiang et al.
BMC CANCER (2013)
Janus Kinase Inhibition with Tofacitinib: Changing the Face of Inflammatory Bowel Disease Treatment
Lucine Vuitton et al.
CURRENT DRUG TARGETS (2013)
Inflammatory bowel disease epidemiology
Johan Burisch et al.
CURRENT OPINION IN GASTROENTEROLOGY (2013)
Influence of polymorphisms and TNF and IL1 beta serum concentration on the infliximab response in Crohn's disease and ulcerative colitis
Diana Lacruz-Guzman et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Tofacitinib: Janus Bifrons in Ulcerative Colitis Treatment
Laurent Peyrin–Biroulet et al.
GASTROENTEROLOGY (2013)
Neutralisation of the interleukin-33/ST2 pathway ameliorates experimental colitis through enhancement of mucosal healing in mice
Mamdouh A. K. Sedhom et al.
GUT (2013)
The burden of inflammatory bowel disease in Europe
Johan Burisch et al.
JOURNAL OF CROHNS & COLITIS (2013)
Recent developments in the treatment of inflammatory bowel disease
Svend T. Rietdijk et al.
JOURNAL OF DIGESTIVE DISEASES (2013)
Expression of interleukin-22/STAT3 signaling pathway in ulcerative colitis and related carcinogenesis
Lian-Zhen Yu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Current and emerging strategies in the management of Crohn's disease
Charles Randall et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2012)
Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, in the treatment of psoriasis: a Phase 2b randomized placebo-controlled dose-ranging study
K. A. Papp et al.
BRITISH JOURNAL OF DERMATOLOGY (2012)
Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review
Natalie A. Molodecky et al.
GASTROENTEROLOGY (2012)
Healing of intestinal inflammation by IL-22
Atsushi Mizoguchi
INFLAMMATORY BOWEL DISEASES (2012)
Interleukin-6-A Key Regulator of Colorectal Cancer Development
Maximilian J. Waldner et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2012)
A Novel Role for Interleukin-27 (IL-27) as Mediator of Intestinal Epithelial Barrier Protection Mediated via Differential Signal Transducer and Activator of Transcription (STAT) Protein Signaling and Induction of Antibacterial and Anti-inflammatory Proteins
Julia Diegelmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
IL-1β mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4+ Th17 cells
Margherita Coccia et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
IL-27 Enhances LPS-Induced Proinflammatory Cytokine Production via Upregulation of TLR4 Expression and Signaling in Human Monocytes
Christina Guzzo et al.
JOURNAL OF IMMUNOLOGY (2012)
Opposing consequences of IL-23 signaling mediated by innate and adaptive cells in chemically induced colitis in mice
J. H. Cox et al.
MUCOSAL IMMUNOLOGY (2012)
IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine
Samuel Huber et al.
NATURE (2012)
Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
Charles A. Dinarello et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Immunotherapy in Inflammatory Bowel Disease
Jatinder P. Ahluwalia
MEDICAL CLINICS OF NORTH AMERICA (2012)
Control of innate and adaptive immunity by the inflammasome
Ceren Ciraci et al.
MICROBES AND INFECTION (2012)
Tofacitinib in Active Ulcerative Colitis
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis
Roy Fleischmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis
Ronald F. van Vollenhoven et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis
William J. Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease
William J. Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
New directions in the basic and translational biology of interleukin-27
Elia D. Tait Wojno et al.
TRENDS IN IMMUNOLOGY (2012)
Efficacy of Biological Therapies in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
Alexander C. Ford et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer
Markus F. Neurath et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2011)
Aryl Hydrocarbon Receptor-Induced Signals Up-regulate IL-22 Production and Inhibit Inflammation in the Gastrointestinal Tract
Ivan Monteleone et al.
GASTROENTEROLOGY (2011)
Interleukin-35 Mediates Mucosal Immune Responses That Protect Against T-Cell-Dependent Colitis
Stefan Wirtz et al.
GASTROENTEROLOGY (2011)
Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study
Christopher D. Williams et al.
GASTROENTEROLOGY (2011)
Genetic polymorphisms of IL-23R and IL-17A and novel insights into their associations with inflammatory bowel disease
Seung Won Kim et al.
GUT (2011)
Serial Changes of Cytokines in Crohn's Disease Treated with Infliximab
Tomomi Mizutani et al.
HEPATO-GASTROENTEROLOGY (2011)
NLRP3 Inflammasome Plays a Key Role in the Regulation of Intestinal Homeostasis
Simon A. Hirota et al.
INFLAMMATORY BOWEL DISEASES (2011)
Interleukin-6 (IL-6) Regulates Claudin-2 Expression and Tight Junction Permeability in Intestinal Epithelium
Takuya Suzuki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Interleukin 1 β (IL-1B) and IL-1 Antagonist Receptor (IL-1RN) Gene Polymorphisms are Associated With the Genetic Susceptibility and Steroid Dependence in Patients With Ulcerative Colitis
Jesus K. Yamamoto-Furusho et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2011)
IL-27 promotes T cell-dependent colitis through multiple mechanisms
Jennifer H. Cox et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
被撤回的出版物: Cutting Edge: Human Regulatory T Cells Require IL-35 To Mediate Suppression and Infectious Tolerance (Retracted article. See vol. 191, pg. 2018, 2013)
Vandana Chaturvedi et al.
JOURNAL OF IMMUNOLOGY (2011)
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47
Carl A. Anderson et al.
NATURE GENETICS (2011)
Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22
Gregory F. Sonnenberg et al.
NATURE IMMUNOLOGY (2011)
MEDICAL PROGRESS Ulcerative Colitis
Silvio Danese et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Induction of regulatory Tr1 cells and inhibition of TH17 cells by IL-27
Caroline Pot et al.
SEMINARS IN IMMUNOLOGY (2011)
Inflammatory Bowel Disease
Arthur Kaser et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Enhand secretion of tumour necrosis factor-alpha, IL-6, and IL-1β by isolated lamina ropria monouclear cells from patients with ulcretive cilitis and Crohn's disease
H.-C. REINECKER et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
The NLRP3 Inflammasome Protects against Loss of Epithelial Integrity and Mortality during Experimental Colitis
Md. Hasan Zaki et al.
IMMUNITY (2010)
IL-33 is upregulated in colonocytes of ulcerative colitis
Jakob Benedict Seidelin et al.
IMMUNOLOGY LETTERS (2010)
Colonic Epithelial Upregulation of Interleukin 22 (IL-22) in Patients with Ulcerative Colitis
Jesus K. Yamamoto-Furusho et al.
INFLAMMATORY BOWEL DISEASES (2010)
Characterization of the Novel ST2/IL-33 System in Patients with Inflammatory Bowel Disease
Carol J. Beltran et al.
INFLAMMATORY BOWEL DISEASES (2010)
Mechanisms by Which Inflammation May Increase Intestinal Cancer Risk in Inflammatory Bowel Disease
Pamela M. O'Connor et al.
INFLAMMATORY BOWEL DISEASES (2010)
Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis
Ayako Kobori et al.
JOURNAL OF GASTROENTEROLOGY (2010)
Essential Roles of IL-6 Trans-Signaling in Colonic Epithelial Cells, Induced by the IL-6/Soluble-IL-6 Receptor Derived from Lamina Propria Macrophages, on the Development of Colitis-Associated Premalignant Cancer in a Murine Model
Satoshi Matsumoto et al.
JOURNAL OF IMMUNOLOGY (2010)
Molecular Pathways in the Induction of Interleukin-27-Driven Regulatory Type 1 Cells
Caroline Pot et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2010)
Involvement of the IL-22/REG Iα axis in ulcerative colitis
Akira Sekikawa et al.
LABORATORY INVESTIGATION (2010)
Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity
Daniel R. Neill et al.
NATURE (2010)
The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27
Lionel Apetoh et al.
NATURE IMMUNOLOGY (2010)
IL-35-mediated induction of a potent regulatory T cell population
Lauren W. Collison et al.
NATURE IMMUNOLOGY (2010)
Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis
Luca Pastorelli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Interleukin-27 as a Negative Regulator of Human Neutrophil Function
J. P. Li et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2010)
Immunological and Inflammatory Functions of the Interleukin-1 Family
Charles A. Dinarello
ANNUAL REVIEW OF IMMUNOLOGY (2009)
IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer
Sergei Grivennikov et al.
CANCER CELL (2009)
STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing
Geethanjali Pickert et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
IL-27 Regulates Homeostasis of the Intestinal CD4+ Effector T Cell Pool and Limits Intestinal Inflammation in a Murine Model of Colitis
Amy E. Troy et al.
JOURNAL OF IMMUNOLOGY (2009)
Common variants at five new loci associated with early-onset inflammatory bowel disease
Marcin Imielinski et al.
NATURE GENETICS (2009)
IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiation
Shlomo Z. Ben-Sasson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
A randomized trial of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease
William J. Sandborn et al.
GASTROENTEROLOGY (2008)
Innate and Adaptive Interleukin-22 Protects Mice from Inflammatory Bowel Disease
Lauren A. Zenewicz et al.
IMMUNITY (2008)
Activation of an IL-6:STAT3-dependent transcriptome in pediatric-onset inflammatory bowel disease
Rebecca Carey et al.
INFLAMMATORY BOWEL DISEASES (2008)
Linking genetic susceptibility to Crohn's disease with Th17 cell function:: IL-22 serum levels are increased in Crohn's disease and correlate with disease activity and IL23R genotype status
Silke Schmechel et al.
INFLAMMATORY BOWEL DISEASES (2008)
Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens
Yan Zheng et al.
NATURE MEDICINE (2008)
The inhibitory cytokine IL-35 contributes to regulatory T-cell function
Lauren W. Collison et al.
NATURE (2007)
Interleukin-6 trans-signaling in inflammatory bowel disease
Keiichi Mitsuyama et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2006)
A genome-wide association study identifies IL23R as an inflammatory bowel disease gene
Richard H. Duerr et al.
SCIENCE (2006)
Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology
Holm H. Uhlig et al.
IMMUNITY (2006)
IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6
D Yen et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration
S Brand et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2006)
Multivalent avimer proteins evolved by exon shuffling of a family of human receptor domains
J Silverman et al.
NATURE BIOTECHNOLOGY (2005)
T helper 1-inducing property of IL-27/WSX-1 signaling is required for the induction of experimental colitis
K Honda et al.
INFLAMMATORY BOWEL DISEASES (2005)
Nod2 mutation in Crohn's disease potentiates NF-κB activity and IL-10 processing
S Maeda et al.
SCIENCE (2005)
Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts
A Andoh et al.
GASTROENTEROLOGY (2005)
Expression of interleukin-12-related cytokine transcripts in inflammatory bowel disease: Elevated interleukin-23p19 and interleukin-27p28 in Crohn's disease but not in ulcerative colitis
C Schmidt et al.
INFLAMMATORY BOWEL DISEASES (2005)
A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease
H Ito et al.
GASTROENTEROLOGY (2004)
IL-12 and IL-23: master regulators of innate and adaptive immunity
CL Langrish et al.
IMMUNOLOGICAL REVIEWS (2004)
Imbalance between interleukin-1 agonists and antagonists: relationship to severity of inflammatory bowel disease
O Ludwiczek et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)
TGF-β suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling
C Becker et al.
IMMUNITY (2004)
Contrasting action of IL-12 and IL-18 in the development of dextran sodium sulphate colitis in mice
H Takagi et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2003)
Colonic epithelial functional phenotype varies with type and phase of experimental colitis
E Mizoguchi et al.
GASTROENTEROLOGY (2003)
Interleukin 18 is a primary mediator of the inflammation associated with dextran sulphate sodium induced colitis: blocking interleukin 18 attenuates intestinal damage
PV Sivakumar et al.
GUT (2002)
IL-27, a heterodimeric cytokine composed of EB13 and p28 protein, induces proliferation of naive CD4+ T cells
S Pflanz et al.
IMMUNITY (2002)
Treatment of T cell-dependent experimental colitis in SCID mice by local administration of an adenovirus expressing IL-18 antisense mRNA
S Wirtz et al.
JOURNAL OF IMMUNOLOGY (2002)
Blockade of endogenous IL-18 ameliorates TNBS-induced colitis by decreasing local TNF-α production in mice
T Ten Hove et al.
GASTROENTEROLOGY (2001)
IL-1β-converting enzyme (caspase-1) in intestinal inflammation
B Siegmund et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist
WF Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
The expression of IL-12 p40 and its homologue Epstien-Barr virus-induced gene 3, in inflammatory bowel disease
F Omata et al.
INFLAMMATORY BOWEL DISEASES (2001)
Identification, cloning, and characterization of a novel soluble receptor that binds IL-22 and neutralizes its activity
SV Kotenko et al.
JOURNAL OF IMMUNOLOGY (2001)
Interleukin 18 is a potent proliferative factor for intestinal mucosal lymphocytes in Crohn's disease
T Kanai et al.
GASTROENTEROLOGY (2000)
Treatment of murine colitis by Lactococcus lactis secreting interleukin-10
L Steidler et al.
SCIENCE (2000)
Frequently relapsing Crohn's disease is characterized by persistent elevation in interleukin-6 and soluble interleukin-2 receptor serum levels during remission
C Van Kemseke et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2000)
IL-6 is required for the development of Th1 cell-mediated murine colitis
M Yamamoto et al.
JOURNAL OF IMMUNOLOGY (2000)
Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation:: Evidence in Crohn disease and experimental colitis in vivo
R Atreya et al.
NATURE MEDICINE (2000)
分享论文
